Changes of Bone Metabolic Markers and Bone Mineral Density After Denosumab and/or Teriparatide Treatment in Japanese Osteoporotic Patients

NCT02156960 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Osteoporosis

Interventions

DRUG: Denosumab treatment in osteoporotic patients
DRUG: Teriparatide treatment in osteoporotic patients
DRUG: Denosumab and teriparatide treatment in osteoporotic patients

Sponsor

Shinshu University